Evidence Hub

New Delhi Metallo-β-Lactamase-5 (NDM-5)-Producing Klebsiella pneumoniae Urinary Tract Infection in a Young Patient Without a History of Overseas Travel: A Case Suggesting Local Spread in Japan

Nishimiura N, Hayashi H, Kuroda M, Kawaguchi T, Nakata H, Yasunaga JI

Cureus, 2026

Abstract

We isolated New Delhi metallo-β-lactamase-5 (NDM-5)-producing Klebsiella pneumoniae KU-00156 from a young individual with no history of overseas travel or exposure to foreign healthcare facilities. During hematologic recovery after chemotherapy for osteosarcoma, the patient developed a urinary tract infection. Urine cultures yielded Klebsiella pneumoniae and Enterococcus faecalis. The K. pneumoniae isolate demonstrated resistance to multiple β-lactam antibiotics, including carbapenems, and PCR-based carbapenemase gene testing confirmed the presence of NDM. Whole-genome analysis revealed that the strain KU-00156 was an NDM-5-producing K. pneumoniae ST290, harboring multiple resistance genes, including bla NDM-5, on an IncHI2-replicon type plasmid. This case represents the detection of NDM-5-producing K. pneumoniae from a young individual without a history of overseas exposure and is considered an important case suggesting the possible prevalence of NDM-5 in the Japanese community.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free